4//SEC Filing
Leproust Emily M. 4
Accession 0001214659-25-015584
CIK 0001581280other
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 4:05 PM ET
Size
12.8 KB
Accession
0001214659-25-015584
Insider Transaction Report
Form 4
Leproust Emily M.
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2025-10-28+168,976→ 770,188 total
Holdings
- 150,879
Employee Stock Option (right to buy)
Exercise: $8.82Exp: 2027-09-28→ Common Stock (0 underlying) - 266,539
Employee Stock Option (right to buy)
Exercise: $26.66Exp: 2028-11-18→ Common Stock (0 underlying) - 64,950
Employee Stock Option (right to buy)
Exercise: $67.85From: 2022-12-19Exp: 2030-08-31→ Common Stock (64,950 underlying) - 0
Employee Stock Option (right to buy)
Exercise: $5.95Exp: 2025-09-28→ Common Stock (0 underlying) - 131,290
Employee Stock Option (right to buy)
Exercise: $23.33Exp: 2029-10-23→ Common Stock (0 underlying)
Footnotes (6)
- [F1]Represents Performance Stock Units for which target criteria was determined to have been met on October 28, 2025. 60% of the PSUs remain subject to time-based vesting and will vest on October 1, 2026, subject to continued service or acceleration of vesting as provided in the award agreement.
- [F2]The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- [F3]The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- [F4]20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- [F5]25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- [F6]Represents performance stock options granted to the reporting person on September 1, 2020, that vested and became exercisable on December 19, 2022 as a result of the reporting person having met the applicable performance criteria.
Documents
Issuer
Twist Bioscience Corp
CIK 0001581280
Entity typeother
Related Parties
1- filerCIK 0001753655
Filing Metadata
- Form type
- 4
- Filed
- Oct 29, 8:00 PM ET
- Accepted
- Oct 30, 4:05 PM ET
- Size
- 12.8 KB